CIK 0001034842 · Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943248524
- Phone
- 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-01 | Schorno Dean L EVP & Chief Financial Officer | Option exercise | +1,200 | $18.70 | $22K | 77,537 |
| 2026-06-01 | Schorno Dean L EVP & Chief Financial Officer | Option exercise | +2,181 | $12.70 | $28K | 79,718 |
| 2026-06-01 | Schorno Dean L EVP & Chief Financial Officer | Shares withheld for taxes | −928 | $29.86 | $28K | 78,790 |
| 2026-06-01 | Schorno Dean L EVP & Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −1,200 | 9,632 | ||
| 2026-06-01 | Schorno Dean L EVP & Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −2,181 | 13,518 | ||
| 2026-06-01 | Santos David A EVP, Chief Commercial Officer | Shares withheld for taxes | −874 | $29.86 | $26K | 61,996 |
| 2026-06-01 | Rojkjaer Lisa EVP, Chief Medical Officer | Shares withheld for taxes | −850 | $29.86 | $25K | 34,003 |
| 2026-06-01 | RODRIGUEZ RAUL R CEO, President | Shares withheld for taxes | −2,424 | $29.86 | $72K | 279,593 |
| 2026-06-01 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Shares withheld for taxes | −877 | $29.86 | $26K | 50,936 |
| 2026-05-26 | Ali-Jackson Kamil Director | Sale 10b5-1 | −2,500 | $29.17 | $73K | 12,625 |
| 2026-05-15 | Wasman Jane Director | Grant or award | +5,750 | 18,250 | ||
| 2026-05-15 | MOOS WALTER H Director | Grant or award | +5,750 | 18,472 | ||
| 2026-05-15 | MILLER MICHAEL PATRICK Director | Grant or award | +5,750 | 5,937 | ||
| 2026-05-15 | LAPOINTE ANTHONY GREGG Director | Grant or award | +5,750 | 18,250 | ||
| 2026-05-15 | HANNAH ALISON L. Director | Grant or award | +5,750 | 16,375 | ||
| 2026-05-15 | Frohlich Mark W Director | Grant or award | +5,750 | 7,000 | ||
| 2026-05-15 | Ali-Jackson Kamil Director | Grant or award | +5,750 | 15,125 | ||
| 2026-02-20 | MOOS WALTER H Director | Option exercise | +4,000 | $24.00 | $96K | 16,722 |
| 2026-02-20 | MOOS WALTER H Director | Sale | −4,000 | $36.36 | $145K | 12,722 |
| 2026-02-20 | MOOS WALTER H Director | Option exercise · Stock Option (right to buy) | −4,000 | 0 |
Page 2 of 9 · 176 trades